Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (131-140 of 233) with videos related to

Pageof 24
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
European Journal of Human Genetics : EJHG|September 2, 2004
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutationsFabio Marroni, Paolo Aretini, Emma D'Andrea, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma projectMassimo Federico, Thomas Rudiger, Monica Bellei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrenceHeikki Joensuu, Piotr Rutkowski, Toshirou Nishida, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
Hematological Oncology|June 4, 2016
Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative studyMonica Bellei, Elena Sabattini, Emanuela Anna Pesce, et al.
Haematologica|June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trialUmberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
European Journal of Human Genetics : EJHG|September 2, 2004
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutationsFabio Marroni, Paolo Aretini, Emma D'Andrea, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma projectMassimo Federico, Thomas Rudiger, Monica Bellei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrenceHeikki Joensuu, Piotr Rutkowski, Toshirou Nishida, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
Hematological Oncology|June 4, 2016
Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative studyMonica Bellei, Elena Sabattini, Emanuela Anna Pesce, et al.
Haematologica|June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trialUmberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
Pageof 24